Skip to main content

Peter Honig

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Peter Honig

Peter Honig was last confirmed as Board Member at Karyopharm Therapeutics Inc. (KPTI) in a filing dated April 11, 2023.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

No call appearances or filed executive changes recorded yet.